Conference Papers
Lizak N; Sharmin S; Walt AVD; Butzkueven H; Lechner-Scott J; Buzzard K; Skibina O; Hodgkinson S; Slee M; John N; Roos I; Kalincik T, 2024, '3 Managing disease activity during treatment with natalizumab in relapsing-remitting multiple sclerosis', in Young Investigators Session Abstracts, BMJ Publishing Group Ltd, pp. A2.1 - A2, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.3
Roos I; Sharmin S; Malpas C; Lechner-Scott J; Hodgkinson S; Walt AVD; Butzkueven H; Buzzard K; Skibina O; John N; Barnett M; Kalincik T, 2024, '3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A43.1 - A43, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.120
Migocki M; Walt AVD; Butzkueven H; Spelman T; Kermode A; Fabis-Pedrini M; Carroll WM; Lechner-Scott J; John N; Barnett M; Hodgkinson S; McCombe P; Kalincik T; Macdonell R; Slee M; Schmitt B, 2024, '3149 Real-world Australian experience with Ofatumumab in the MSBase registry', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A45.3 - A46, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.127
De Stefano N; Achiron A; Barkhof F; Chan A; Derfuss T; Hodgkinson S; Leocani L; Montalban X; Prat A; Schmierer K; Sellebjerg F; Vermersch P; Wiendl H; Keller B; Smyk A; Gardner L, 2023, 'Early Onset of Action and Sustained Efficacy of MRI Outcomes During Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-year MAGNIFY-MS Study (P6-3.018)', in Neurology, Ovid Technologies (Wolters Kluwer Health), http://dx.doi.org/10.1212/wnl.0000000000202977
Wiendl H; De Stefano N; Barkhof F; Montalban X; Achiron A; Derfuss T; Chan A; Hodgkinson S; Prat A; Leocani L; Schmierer K; Sellebjerg F; Vermersch P; Jin H; Jarvinen E; Chudecka A; Gardner L, 2023, 'Blood Biomarker Dynamics in Highly Active Relapsing Multiple Sclerosis Patients Treated With Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, MA, Boston, presented at 75th Annual Meeting of the American-Academy-of-Neurology (AAN), MA, Boston, 22 April 2023 - 27 April 2023, http://dx.doi.org/10.1212/WNL.0000000000202961
Hardy T; Aouad P; Barnett M; Blum S; Broadley S; Carroll W; Crimmins D; Griffiths D; Hodgkinson S; Lechner-Scott J; Lee A; Malhotra R; McCombe P; Parratt J; Plummer C; Walt AVD; Martel K; Walker R, 2023, '2723 Secondary progressive multiple sclerosis patients in Australia treated with siponimod; novel real-world evidence from the MSGo digital support program', in Poster Abstract, BMJ Publishing Group Ltd, pp. A41.2 - A41, presented at ANZAN Annual Scientific Meeting 2023 Abstracts, http://dx.doi.org/10.1136/bmjno-2023-anzan.113
Hardy T; Aouad P; Barnett M; Blum S; Broadley S; Carroll W; Crimmins D; Griffiths D; Hodgkinson S; Lechner-Scott J; Lee A; Malhotra R; McCombe P; Parratt J; Plummer C; Van der Walt A; Martel K; Walker R, 2023, 'Novel Real World Evidence from MSGo, a Digital Support Program for Secondary Progressive Multiple Sclerosis Patients in Australia using Siponimod', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. NP44 - NP46
Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; van der Walt A; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2022, 'Comparison of multiple disease modifying therapies in multiple sclerosis with marginal structural models', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 5 - 6, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022
Sharmin S; Malpas C; Lechner-Scott J; Slee M; McCombe P; Vucic S; Butler E; Hodgkinson S; Barnett M; Skibina O; van der Walt A; Buzzard K; Shaw C; Kermode A; Taylor B; Shuey N; Macdonell R; Butzkueven H; Kalincik T, 2022, 'Confirmed disability progression as a marker of permanent disability in multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 8 - 8, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022
Sharmin S; Malpas C; Lechner-Scott J; Slee M; McCombe P; Vucic S; Butler E; Hodgkinson S; Barnett M; Skibina O; van der Walt A; Buzzard K; Shaw C; Kermode A; Taylor B; Shuey N; Macdonell R; Butzkueven H; Kalincik T, 2022, 'Confirmed disability progression as a marker of permanent disability in multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 8 - 8, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022
Roos I; Malpas CB; Leray E; Buzzard K; Skibina O; Lechner-Scott J; McCombe P; Slee M; Butler E; Macdonell R; van der Walt A; Hodgkinson S; Barnett M; Vucic S; Vukusic S; Butzkueven H; Kalincik T, 2022, 'Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 6 - 7, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022
Zhong M; van der Walt A; Hodgkinson S; Kalincik T; Izquierdo G; Eichau S; Grand'Maison F; Lechner-Scott J; Buzzard K; Skibina O; Butler E; Prevost J; McCombe P; Van Pesch V; Oh J; Butzkueven H; Jokubaitis V, 2022, 'Time to relapse after switching to cladribine is predicted by relapse during the washout period', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 11 - 11, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022
Hardy T; Aouad P; Blum S; Broadley S; Carroll W; Crimmins D; Griffiths D; Hodgkinson S; Lechner-Scott J; Lee A; Malhotra R; Parratt J; Plummer C; Walt AVD; Walker R, 2022, '2258 Novel generation of real-world evidence through MSGo, a digital support program supporting the use of siponimod in secondary progressive multiple sclerosis patients in Australia', in Abstracts, BMJ Publishing Group Ltd, pp. A25.1 - A25, presented at ANZAN Annual Scientific Meeting 2022 Abstracts, http://dx.doi.org/10.1136/bmjno-2022-anzan.64
Vitkova M; Diouf I; Malpas C; Barnett M; Hodgkinson S; Butler E; Slee M; Taylor B; Butzkueven H; Lechner-Scott J; McCombe P; Vucic S; Macdonell R; Shaw C; Kalincik T, 2022, '2327 Latitude, UVR and multiple sclerosis severity', in Abstracts, BMJ Publishing Group Ltd, pp. A11.3 - A12, presented at ANZAN Annual Scientific Meeting 2022 Abstracts, http://dx.doi.org/10.1136/bmjno-2022-anzan.29
Maltby VE; Lea RA; Monif M; Fabis-Pedrini MJ; Buzzard K; Kalincik T; Kermode AG; Taylor B; Hodgkinson S; McCombe P; Osborne M; Butzkueven H; Barnett M; Lechner-Scott J, 2022, 'Cladribine: a multicentre, LOng-term efficacy and Biomarker Australian Study (CLOBAS)', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 26 - 26
Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; van der Walt A; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2022, 'Comparison of multiple disease modifying therapies in multiple sclerosis with marginal structural models', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 5 - 6
Roos I; Malpas CB; Leray E; Buzzard K; Skibina O; Lechner-Scott J; McCombe P; Slee M; Butler E; Macdonell R; van der Walt A; Hodgkinson S; Barnett M; Vucic S; Vukusic S; Butzkueven H; Kalincik T, 2022, 'Disease reactivation after cessation of diseasemodifying therapy in relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 6 - 7
Zhong M; van der Walt A; Hodgkinson S; Kalincik T; Izquierdo G; Eichau S; Grand'Maison F; Lechner-Scott J; Buzzard K; Skibina O; Butler E; Prevost J; McCombe P; Van Pesch V; Oh J; Butzkueven H; Jokubaitis V, 2022, 'Time to relapse after switching to cladribine is predicted by relapse during the washout period', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 11 - 11
Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; van der Walt A; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2022, 'Variability of the response to immunotherapy among sub-groups of patients with multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 7 - 7
Yeh WZ; Widyastuti PA; Walt AVD; Stankovich J; Havrdova EK; Horakova D; Vodehnalova K; Ozakbas S; Eichau S; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout B; Lechner-Scott J; Sola P; Skibina O; Barnett M; Onofrj M; Sá MJ; McCombe P; Grammond P; Ampapa R; Grand’Maison F; Bergamaschi R; Spitaleri DLA; Pesch VV; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Gresle M; Uher T; Maimone D; Turkoglu R; Hupperts RMM; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell R; Castillo-Trivino T; Butzkueven H; Alroughani R; Jokubaitis VG; Registry M, 2021, '004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis', in Oral abstracts, BMJ Publishing Group Ltd, pp. A2.1 - A2, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.4
Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; Walt AVD; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2021, '006 Comparison of multiple disease modifying therapies in multiple sclerosis with marginal structural models', in Oral abstracts, BMJ Publishing Group Ltd, pp. A3.1 - A3, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.6
Roos I; Malpas CB; Leray E; Buzzard K; Skibina O; Lechner-Scott J; McCombe P; Slee M; Butler E; Macdonell R; Walt AVD; Hodgkinson S; Barnett M; Vucic S; Vukusic S; Butzkueven H; Kalincik T, 2021, '008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis', in Oral abstracts, BMJ Publishing Group Ltd, pp. A4.1 - A4, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.8
Butzkueven H; Spelman T; Kalincik T; Buzzard K; Walt AVD; Lechner-Scott J; Hodgkinson S; Butler E; Macdonell R; Slee M; Group MS; Marcel B, 2021, '010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort', in Oral abstracts, BMJ Publishing Group Ltd, pp. A4.3 - A5, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.10
Yeh W; Widyastuti P; Van der Walt A; Stankovich J; Gresle M; Havrdova E; Horakova D; Vodehnalova K; Ozakbas S; Eichau S; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout B; Lechner-Scott J; Sola P; Skibina O; Barnett M; Onofrj M; Sa MJ; Mccombe P; Grammond P; Ampapa R; Grand'Maison F; Bergamaschi R; Spitaleri D; Van Pesch V; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Uher T; Maimone D; Turkoglu R; Hupperts R; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell R; Castillo-Trivino T; Butzkueven H; Alroughani R; Jokubaitis V, 2020, 'Pregnancy in a modern day multiple sclerosis cohort: predictors of relapse during pregnancy', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, pp. 30 - 31, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Butzkueven H; Spelman T; Hodgkinson S; Kalincik T; Buzzard K; Skibina O; Eichau Madueno S; Izquierdo G; Van der Walt A; Grand-Maison F; Butler E; Prevost J; Mccombe P; Oh J; Macdonell R; Lechner-Scott J; Van Pesch V; Duquette P; Prat A; Girard M; Kermode A; Fabris J, 2020, 'Real-world experience with cladribine tablets in the msbase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, pp. 549 - 549, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547101671&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
De Stefano N; Achiron A; Barkhof F; Chan A; Derfuss T; Hodgkinson S; Leocani L; Montalbant X; Pratt A; Schmierer K; Sellebjerg F; Vermersch P; Wiendl H; Keller B; Roy S, 2020, 'A 2-year Study to Evaluate the Onset of Action of Cladribine Tablets in Subjects with Highly Active Relapsing Multiple Sclerosis: Results from MAGNIFY- MS Baseline Analysis', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, ELECTR NETWORK, pp. 685 - 686, presented at 6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 May 2020 - 26 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000534616801566&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Malpas CB; Roos I; Sharmin S; Butzkueven H; Kappos L; Patti F; Alroughani R; Horakova D; Havrdova EK; Izquierdo G; Eichau S; Hodgkinson S; Grammond P; Lechner-Scott J; Kalincik T, 2019, 'Disease reactivation following fingolimod cessation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 330 - 331, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303101223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Butzkueven H; Spelman T; Patti F; Eichau S; Grand'Maison F; Kalincik T; Hodgkinson S; Skibina O; Butler E, 2019, 'Real-world experience with Cladribine in the MSBase Registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 326 - 327, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303101217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Butzkueven H; Spelman T; Patti F; Ozakbas S; Eichau S; Alroughani R; Terzi M; Boz C; Grand'Maison F; Grammond P; Kalincik T; Van Pesch V; Lechner-Scott J; Barnett M; Kuhle J; Hodgkinson S; Skibina O; Soysal A; Butler E; Slee M; Prevost J; Laureys G; Macdonell R; van Beek J; Craveiro L; Wormser D; Muros-Le Rouzic E, 2019, 'Real-world experience with Ocrelizumab in the MSBase Registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 539 - 540, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303102197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Hodgkinson S; Sharma M, 2019, 'Temporal profile of lymphocytes following treatment with cladribine tablets in patients switching from lymphocyte depleting or sequestering diseased modifying drugs (DMDs)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, PA, Philadelphia, presented at 71st Annual Meeting of the American-Academy-of-Neurology (AAN), PA, Philadelphia, 04 May 2019 - 10 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000475965903372&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Haartsen J; Spelman T; Baker J; Agland S; Lechner-Scott J; Burke T; Vucic S; Rath L; Skibina O; Toubia M; Slee M; Taylor B; Mac Gregor S; Oconnell AM; Barnett M; Baker S; Sharma M; Hodgkinson S; Walters S; Kermode A; Hayes W; Butler E; Sheuy N; Shaw C; Portley R; Hardy T; Tan IL; Butzkueven H, 2017, 'MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 403 - 404, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
Kister I; Spelman T; Patti F; Duquette P; Trojano M; Izquierdo G; Lugaresi A; Grammond P; Sola P; Ferraro D; Grand'Maison F; Alroughani R; Terzi M; Boz C; Hupperts R; Lechner-Scott J; Kapos L; Pucci E; Hodgkinson S; Solaro C; Butzkueven H, 2017, 'Predictors of relapses and disability progression after stopping disease-modifying therapies for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 356 - 357, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
Jokubaitis VG; Havrdova E; Horakova D; Izquierdo G; Kalincik T; van der Walt A; Nguyen A-L; Terzi M; Alroughani R; Duquette P; Girard M; Prat A; Boz C; Sola P; Lugaresi A; Lechner-Scott J; Barnett M; Grand'Maison F; Grammond P; Ramo C; Turkoglu R; McCombe P; Hupperts R; Bolanos RF; Pucci E; Trojano M; Granella F; Spitaleri D; Van Pesch V; Soysal A; Oreja-Guevara C; Verheul F; Vucic S; Hodgkinson S; Slee M; Ampapa R; Prevost J; Menoyo JLS; Skibina O; Iuliano G; Solaro C; Olascoaga J; Shaw C; Madsen K; Naidoo K; Hyde R; Butzkueven H, 2017, 'Pregnancy incidence and therapy exposure in relapsing forms of MS: a 12-year retrospective multicentre analysis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 130 - 132, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
Kalincik T; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Lechner-Scott J; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Solaro C; Grand'Maison F; Hupperts R; Prevost J; Sola P; Ferraro D; Terzi M; Butler E; Slee M; Kermode A; Fabis-Pedrini M; McCombe P; Barnett M; Shaw C; Hodgkinson S; Butzkueven H, 2017, 'Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 596 - 597, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730203308&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Kalincik T; Spelman T; Jokubaitis V; Horakova D; Havrdova E; Izquierdo G; Prat A; Girard M; Duquette P; Lugaresi A; Grammond P; Alroughani R; Lechner-Scott J; Prevost J; Terzi M; Grand'Maison F; Boz C; Trojano M; Van Wijmeersch B; Pucci E; Granella F; Turkoglu R; Sola P; Ferraro D; McCombe P; Solaro C; Van Pesch V; Ozakbas S; Slee M; Spitaleri D; Sanchez-Menoyo JL; Ampapa R; Hodgkinson S; Karabudak R; Vucic S; Butzkueven H, 2017, 'Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 325 - 327, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730202066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Spelman T; Schulz M; Arora B; Chung E; Juneja P; Walker R; Verhaeghe S; Butzkueven H; Hodgkinson S; Lechner-Scott J; McCombe P; Slee M; Butler E; Barnett M; Skibina O; Vucic S; Macdonell R; Shuey N; Taylor B; Broadley S, 2017, 'Persistence to fingolimod compared with other disease modifying therapies in the Australian real-world setting using the MS base registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 631 - 631, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730204050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Jokubaitis V; Ai-Lan N; Kalincik T; van der Walt A; Lechner-Scott J; Barnett M; McCombe P; Vucic S; Hodgkinson S; Slee M; Skibina O; Shaw C; Butzkueven H, 2017, 'Pregnancy incidence, therapy exposure and post-partum relapse risk: a 12-year retrospective multicentre analysis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, pp. NP4 - NP4, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Firtko A; Thomas P; Hodgkinson S, 2017, 'Effect of Post-Acute Nurse Led Stroke Clinic (PASC) on readmissions rates for TIA/Stroke', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, pp. 10 - 11, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408220500026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Jokubaitis VG; Li V; Kalincik T; Izquierdo G; Hodgkinson S; Alroughani R; Lechner-Scott J; Lugaresi A; Duquette P; Girard M; Barnett M; Grand'Maison F; Trojano M; Slee M; Giuliani G; Shaw C; Boz C; Haartsen J; Liew D; Butzkueven H, 2013, 'Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, DENMARK, Copenhagen, pp. 55 - 56, presented at 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, DENMARK, Copenhagen, 02 October 2013 - 05 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000328751400086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Cordato DJ; Thomas PR; Darshan G; Sanjeev T; Worthington JM; McDougall AJ; Hodgkinson SJ; Ibrahim HY; Griffith NC; Cappelen-Smith C; Beran RG, 2010, 'Decreasing Presentations of Seizures to Emergency Departments in a Large Australian Population', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, pp. A258 - A258, presented at 62nd Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 10 April 2010 - 17 April 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275274001259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
LINDSEY JW; HODGKINSON S; MEHTA R; ENZMANN D; SANDERS M; STEINMAN L, 1993, 'PHASE-I STUDY OF REPEATED TREATMENT WITH CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LIPPINCOTT-RAVEN PUBL, pp. A280 - A281, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KY35600489&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
LINDSEY JW; HODGKINSON S; MEHTA R; SIEGEL RC; MITCHELL DJ; LIM M; PIERCY C; TRAM T; DORFMAN L; ENZMANN D; STEINMAN L, 1992, 'PHASE-1 CLINICAL-TRIAL OF CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LITTLE BROWN CO, CA, SAN DIEGO, pp. 413 - 419, presented at 44th Annual Meeting of the American-Academy-of-Neurology, CA, SAN DIEGO, http://dx.doi.org/10.1212/WNL.44.3_Part_1.413
Back to profile page
https://orcid.org/0000-0002-9029-6663